1. Home
  2. NTCT vs ARQT Comparison

NTCT vs ARQT Comparison

Compare NTCT & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTCT
  • ARQT
  • Stock Information
  • Founded
  • NTCT 1984
  • ARQT 2016
  • Country
  • NTCT United States
  • ARQT United States
  • Employees
  • NTCT N/A
  • ARQT N/A
  • Industry
  • NTCT EDP Services
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTCT Technology
  • ARQT Health Care
  • Exchange
  • NTCT Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • NTCT 1.7B
  • ARQT 1.7B
  • IPO Year
  • NTCT 1999
  • ARQT 2020
  • Fundamental
  • Price
  • NTCT $21.61
  • ARQT $13.53
  • Analyst Decision
  • NTCT Hold
  • ARQT Strong Buy
  • Analyst Count
  • NTCT 1
  • ARQT 6
  • Target Price
  • NTCT $25.00
  • ARQT $18.80
  • AVG Volume (30 Days)
  • NTCT 426.5K
  • ARQT 2.1M
  • Earning Date
  • NTCT 05-08-2025
  • ARQT 05-06-2025
  • Dividend Yield
  • NTCT N/A
  • ARQT N/A
  • EPS Growth
  • NTCT N/A
  • ARQT N/A
  • EPS
  • NTCT N/A
  • ARQT N/A
  • Revenue
  • NTCT $822,679,000.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • NTCT $0.22
  • ARQT $57.99
  • Revenue Next Year
  • NTCT $2.04
  • ARQT $41.24
  • P/E Ratio
  • NTCT N/A
  • ARQT N/A
  • Revenue Growth
  • NTCT N/A
  • ARQT 100.03
  • 52 Week Low
  • NTCT $17.10
  • ARQT $6.99
  • 52 Week High
  • NTCT $27.89
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • NTCT 61.28
  • ARQT 42.73
  • Support Level
  • NTCT $19.98
  • ARQT $12.42
  • Resistance Level
  • NTCT $22.34
  • ARQT $15.67
  • Average True Range (ATR)
  • NTCT 0.64
  • ARQT 0.84
  • MACD
  • NTCT 0.13
  • ARQT -0.07
  • Stochastic Oscillator
  • NTCT 70.45
  • ARQT 34.15

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: